Recursion Pharmaceuticals Stock Price on August 9, 2024
| RXRX Stock | USD 7.07 0.69 10.82% |
If you're considering investing in Recursion Stock, it is important to understand the factors that can impact its price. As of today, the current price of Recursion Pharmaceuticals stands at 7.07, as last reported on the 30th of November, with the highest price reaching 7.14 and the lowest price hitting 6.44 during the day. Recursion Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Recursion Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0793, which implies the firm had a 0.0793% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Recursion Pharmaceuticals, which you can use to evaluate the volatility of the company. Please evaluate Recursion Pharmaceuticals' Coefficient Of Variation of 11523.61, risk adjusted performance of 0.0149, and Semi Deviation of 4.98 to confirm if our risk estimates are consistent with your expectations.
At this time, Recursion Pharmaceuticals' Other Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to rise to about 56.2 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 255.6 M in 2024. . At this time, Recursion Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 4.64 in 2024, whereas Price To Sales Ratio is likely to drop 43.68 in 2024. Recursion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Recursion |
Sharpe Ratio = 0.0793
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RXRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.08 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Recursion Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Recursion Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 4.7305 | Enterprise Value Ebitda (5.31) | Price Sales 38.0682 | Shares Float 252.4 M | Wall Street Target Price 9.8571 |
Related Headline
AVROBIO Headline on 20th of June 2024
Tectonic, AVROBIO complete merger, announce 130.7M private p... by seekingalpha.com
Tectonic Therapeutic announced the closing of its planned merger with AVROBIO , along with a concurrent 130.7 private placement. Read more here.
Recursion Pharmaceuticals Valuation on August 9, 2024
It is possible to determine the worth of Recursion Pharmaceuticals on a given historical date. On August 9, 2024 Recursion was worth 6.83 at the beginning of the trading date compared to the closed value of 6.29. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Recursion Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Recursion Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Recursion Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Recursion Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 6.50 | 6.82 | 6.42 | 6.64 | 7,387,152 | |
08/09/2024 | 6.83 | 7.03 | 6.25 | 6.29 | 8,665,536 |
| 6.25 | 6.29 | 5.96 | 6.03 | 5,859,370 |
| Backtest Recursion Pharmaceuticals | | | Recursion Pharmaceuticals History | | | Recursion Pharmaceuticals Valuation | Previous | Next |
Recursion Pharmaceuticals Trading Date Momentum on August 9, 2024
| On August 12 2024 Recursion Pharmaceuticals was traded for 6.03 at the closing time. The top price for the day was 6.29 and the lowest listed price was 5.96 . The trading volume for the day was 5.9 M. The trading history from August 12, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 4.13% . The trading delta at closing time against the current closing price is 7.47% . |
Recursion Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Recursion Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Recursion Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Recursion financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Recursion Pharmaceuticals Stock history
Recursion Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Recursion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Recursion Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Recursion Pharmaceuticals stock prices may prove useful in developing a viable investing in Recursion Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 207.9 M | 194.8 M | |
| Net Loss | -215.5 M | -226.3 M |
Recursion Pharmaceuticals Quarterly Net Working Capital |
|
Recursion Pharmaceuticals Stock Technical Analysis
Recursion Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Recursion Pharmaceuticals Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Recursion Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Recursion Pharmaceuticals November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Recursion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Recursion Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Recursion Pharmaceuticals stock market strength indicators, traders can identify Recursion Pharmaceuticals entry and exit signals to maximize returns
Recursion Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Recursion Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Recursion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Recursion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0149 | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.72) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0127 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Recursion Stock Analysis
When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.